Journal of Substance Abuse Treatment This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Evaluation of an injectable monthly extended-release buprenorphine program in a low-barrier specialty addiction medicine clinic
Monthly injectable extended-release buprenorphine (XR-BUP) can address several systemic and individual barriers to consistent sublingual buprenorphine treatment for patients with opioid use disorder (OUD). Real-world evaluations of XR-BUP in the outpatient addiction treatment setting are limited. The purpose of this study was to compare 6-month treatment retention and urine drug tests between patients who initiated XR-BUP compared to those who were prescribed but did not initiate XR-BUP in a low-barrier addiction medicine specialty clinic. (Source: Journal of Substance Abuse Treatment)
Source: Journal of Substance Abuse Treatment - October 22, 2023 Category: Addiction Authors: Jessica Heil, Matthew Salzman, Krystal Hunter, Kaitlan E. Baston, Christopher Milburn, Ryan Schmidt, Rachel Haroz, Valerie S. Ganetsky Source Type: research

A thematic analysis of stress, substance-cue, and neutral/relaxing events to inform approaches for improving treatment among black adults who use substances
To inform approaches for adapting substance use treatment for Black adults, the aim of this study was to thematically analyze the stressors, triggers for substance use, and neutral/relaxing events reported among Black adults who participated in a lab paradigm. (Source: Journal of Substance Abuse Treatment)
Source: Journal of Substance Abuse Treatment - October 20, 2023 Category: Addiction Authors: Angela M. Haeny, Aishwarya Chowdhary, Jaelen King, Isaiah Sypher, Stephanie S. O'Malley, Rajita Sinha Source Type: research

Predictive role of impulsivity, anxiety, and depression in the efficacy of intermittent theta burst transcranial magnetic stimulation modalities for treating methamphetamine use disorder: A randomized clinical trial
Methamphetamine use disorder (MUD) can cause impulsive behavior, anxiety, and depression. Stimulation of the left dorsolateral prefrontal cortex in MUD patients by intermittent theta burst repetitive transcranial magnetic stimulation (iTBS-rTMS) is effective in reducing cravings, impulsive behavior, anxiety, and depression. The purpose of this study was to explore whether these psychological factors helped to predict MUD patients' responses to iTBS-rTMS treatment. (Source: Journal of Substance Abuse Treatment)
Source: Journal of Substance Abuse Treatment - October 20, 2023 Category: Addiction Authors: Zixuan Ren, Linlin Mu, Lijin Wang, Lingling Xia, Peipei Song, Yan Wang, Junda Li, Fan Duan, Haonan Li, Huajun Tang, Wenjuan Wang, Lin Zhu, Lei Zhang, Xun Song, Yujing Wang, Wei Zhao, Yuqiong Zhu, Ze Wang, Wenyi Shao, Xiaochu Zhang, Dongliang Jiao Source Type: research

Gender differences in receipt of telehealth versus in person behavioral therapy, medication for opioid use disorder (MOUD), and 90-day MOUD retention during the pandemic: A retrospective veteran cohort study
In this study, we evaluated gender differences in utilization of behavioral therapy in person and via telehealth, MOUD utilization, and achieving 90-day MOUD retention pre-post pandemic onset, given known gender differences in treatment utilization between men and women. (Source: Journal of Substance Abuse Treatment)
Source: Journal of Substance Abuse Treatment - October 19, 2023 Category: Addiction Authors: Nicholas A. Livingston, Alexis Sarpong, Rebecca Sistad, Clara Roth, Anne N. Banducci, Tracy Simpson, Justeen Hyde, Michael Davenport, Risa Weisberg Source Type: research

Development and validation of a community-level social determinants of health index for drug overdose deaths in the HEALing Communities Study
This study develops a novel index tailored to opioid misuse outcomes, tests the efficacy of this index in predicting drug overdose deaths across contexts, and compares the explanatory power of this index to other SDoH indices. (Source: Journal of Substance Abuse Treatment)
Source: Journal of Substance Abuse Treatment - October 19, 2023 Category: Addiction Authors: Nina Cesare, Lisa M. Lines, Redonna Chandler, Erin Gibson, Rachel Vickers-Smith, Rebecca Jackson, Angela R. Bazzi, Dawn Goddard-Eckrich, Nasim Sabounchi, Deena Chisolm, Nathan Vandergrift, Emmanuel Oga Source Type: research

Gender differences in utilization of behavioral therapy and medication for opioid use disorder during the pandemic: A retrospective veteran cohort study
In this study, we evaluated gender differences in utilization of behavioral therapy in person and via telehealth, MOUD utilization, and achieving 90-day MOUD retention pre-post pandemic onset, given known gender differences in treatment utilization between men and women. (Source: Journal of Substance Abuse Treatment)
Source: Journal of Substance Abuse Treatment - October 19, 2023 Category: Addiction Authors: Nicholas A. Livingston, Alexis Sarpong, Rebecca Sistad, Clara Roth, Anne N. Banducci, Tracy Simpson, Justeen Hyde, Michael Davenport, Risa Weisberg Source Type: research

“If you're strung out and female, they will take advantage of you”: A qualitative study exploring drug use and substance use service experiences among women in Boston and San Francisco
Significant disparities in substance use severity and treatment persist among women who use drugs compared to men. Thus, we explored how identifying as a woman was related to drug use and treatment experiences. (Source: Journal of Substance Abuse Treatment)
Source: Journal of Substance Abuse Treatment - October 19, 2023 Category: Addiction Authors: Miriam T.H. Harris, Jordana Laks, Emily Hurstak, Jennifer P. Jain, Audrey M. Lambert, Ariel D. Maschke, Sarah M. Bagley, John Farley, Phillip O. Coffin, Vanessa M. McMahan, Cynthia Barrett, Alexander Y. Walley, Christine M. Gunn Source Type: research

A smoking cessation intervention for rural veterans tailored to individual risk factors: A multicenter randomized clinical trial
Rates of cigarette use remain elevated among those living in rural areas. Depressive symptoms, risky alcohol use, and weight concerns frequently accompany cigarette smoking and may adversely affect quitting. Whether treatment for tobacco use that simultaneously addresses these issues affects cessation outcomes is uncertain. (Source: Journal of Substance Abuse Treatment)
Source: Journal of Substance Abuse Treatment - October 19, 2023 Category: Addiction Authors: Mark W. Vander Weg, M. Bryant Howren, Kathleen M. Grant, Allan V. Prochazka, Sonia Duffy, Randy Burke, Margaret Cretzmeyer, Christopher Parker, Emily B.K. Thomas, Marianne T. Rizk, Jennifer Bayer, Ellen M. Kinner, Jennifer M. Clark, David A. Katz Source Type: research

The role of co-occurring disorders in criminal recidivism and psychiatric recovery among adults with opioid use disorder and criminal-legal involvement: A statewide retrospective cohort study
Individuals with opioid use disorder (OUD) in the criminal-legal system commonly present co-occurring mental health disorders. However, evidence-based treatment for high-risk populations such as those with co-occurring disorders is often unavailable within jails and prisons. Coordination of timely and affordable access to behavioral health treatment following incarceration is critical to address the multidimensional needs of people with co-occurring needs. However, the role of co-occurring disorders among adults with OUD and criminal-legal involvement who are accessing community-based treatment is understudied. (Source: Jo...
Source: Journal of Substance Abuse Treatment - October 19, 2023 Category: Addiction Authors: Spencer G. Lawson, Chelsea M.A. Foudray, Evan M. Lowder, Bradley Ray, Kory L. Carey Source Type: research

A qualitative assessment of tablet injectable opioid agonist therapy (TiOAT) in rural and smaller urban British Columbia, Canada: Motivations and initial impacts
The evolving and unpredictable unregulated drug market has driven an unprecedented overdose crisis that requires effective intervention. Growing evidence suggests that novel opioid agonist treatments, such as tablet injectable opioid agonist therapy (TiOAT), have potential to prevent overdoses and other drug-related harms. More evidence is needed to characterize their utility in achieving these outcomes. The current article is an analysis of two TiOAT programs implemented in British Columbia, Canada, to assess impact on health and well-being, including overdose risk. (Source: Journal of Substance Abuse Treatment)
Source: Journal of Substance Abuse Treatment - October 19, 2023 Category: Addiction Authors: Jeanette Bowles, Manal Mansoor, Dan Werb, Thomas Kerr, Geoff Bardwell Source Type: research

Usability and feasibility of a take-home methadone web-application for opioid treatment program patients: A Small Business Innovation Research mixed methods study
Most patients in opioid treatment programs (OTPs) attend daily for observed dosing. A Stage IA (create and adapt) and a Stage IB (feasibility and pilot) mixed method studies tested a web-application (app) designed to facilitate access to take-home methadone. (Source: Journal of Substance Abuse Treatment)
Source: Journal of Substance Abuse Treatment - October 17, 2023 Category: Addiction Authors: Michael Giles, Lucy Reynales, Avinash Jayaraman, Omer Kaplan, Kshitij Verma, Katharina Wiest, Samuel Denney, Cora Hart, Steffani R. Bailey, Dongseok Choi, Kim A. Hoffman, Mark P. McGovern, Dennis McCarty Source Type: research

Barriers and facilitators to the involvement of general practitioners in the prescription of buprenorphine
France has one of the highest opioid agonist treatment (OAT) coverage rates in the world. French general practitioners (GPs) are providing the majority of prescriptions. However, a fall in the number of GPs initiating buprenorphine has been observed over the last decade. (Source: Journal of Substance Abuse Treatment)
Source: Journal of Substance Abuse Treatment - October 17, 2023 Category: Addiction Authors: La ëtitia Gimenez, Délia Bonis, Mathilde Morel, Aurore Palmaro, Lise Dassieu, Julie Dupouy Source Type: research

Latent class analysis of perceived stigma among older adults receiving medications for opioid use disorder
Public stigma surrounds individuals who use medication for their recovery from a substance use disorder. However, we know little about subgroups of individuals with varying levels of perceived stigma and how these levels may be associated with physical and mental health-related quality of life (HRQOL) and social support. (Source: Journal of Substance Abuse Treatment)
Source: Journal of Substance Abuse Treatment - October 17, 2023 Category: Addiction Authors: Mary M. Mitchell, Sahil Angelo, Olusegun G. Akinwolere, Molly M. Perkins, Alexis A. Bender Source Type: research

Stakeholder perspectives on a telemedicine referral and coordination model to expand medication treatment for opioid use disorder in rural primary care clinics
Opioid overdose deaths are increasing rapidly in the United States. Medications for opioid use disorder (MOUD) are effective and can be delivered in primary care, but uptake has been limited in rural communities. Referral to and coordination with an external telemedicine (TM) vendor by rural primary care clinics for MOUD (TM-MOUD) may increase MOUD access for rural patients, but we know little about perspectives on this model among key stakeholders. As part of a TM-MOUD feasibility study, we explored TM-MOUD acceptability and feasibility among personnel and patients from seven rural primary care clinics and a TM-MOUD vendo...
Source: Journal of Substance Abuse Treatment - October 17, 2023 Category: Addiction Authors: Allison J. Ober, Alex R. Dopp, Sarah E. Clingan, Megan E. Curtis, Chunqing Lin, Stacy Calhoun, Sherry Larkins, Megan Black, Maria Hanano, Katie P. Osterhage, Laura-Mae Baldwin, Andrew J. Saxon, Emily G. Hichborn, Lisa A. Marsch, Larissa J. Mooney, Yih-Ing Source Type: research

Pharmacy-based expansion of buprenorphine access
Access to evidence-based medication treatment is a challenge for most Americans with opioid use disorder. New models of collaborative care that actively incorporate pharmacists are being trialed. (Source: Journal of Substance Abuse Treatment)
Source: Journal of Substance Abuse Treatment - October 17, 2023 Category: Addiction Authors: Seth A. Clark, Traci C. Green, Josiah D. Rich Tags: Commentary Source Type: research